<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">2985117R</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">4816</journal-id>
      <journal-id journal-id-type="nlm-ta">J Immunol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Immunol</journal-id>
      <journal-title-group>
        <journal-title>Journal of immunology (Baltimore, Md. : 1950)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-1767</issn>
      <issn pub-type="epub">1550-6606</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">37036290</article-id>
      <article-id pub-id-type="pmc">10159994</article-id>
      <article-id pub-id-type="doi">10.4049/jimmunol.2300071</article-id>
      <article-id pub-id-type="manuscript">NIHMS1884164</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Single Nasal Dose Vaccination with a <italic toggle="yes">Brucella abortus</italic> Mutant Potently Protects Against Pulmonary Infection</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Hongbin</given-names>
          </name>
          <xref rid="A1" ref-type="aff">*</xref>
          <xref rid="FN1" ref-type="author-notes">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Clapp</surname>
            <given-names>Beata</given-names>
          </name>
          <xref rid="A1" ref-type="aff">*</xref>
          <xref rid="FN2" ref-type="author-notes">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoffman</surname>
            <given-names>Carol</given-names>
          </name>
          <xref rid="A1" ref-type="aff">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Xinghong</given-names>
          </name>
          <xref rid="A1" ref-type="aff">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6572-6916</contrib-id>
          <name>
            <surname>Pascual</surname>
            <given-names>David W.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">*</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>*</label> Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL</aff>
      <author-notes>
        <fn fn-type="current-aff" id="FN1">
          <label>1</label>
          <p id="P1">Current address: Bristol-Myers Squibb, San Francisco, CA.</p>
        </fn>
        <fn fn-type="current-aff" id="FN2">
          <label>2</label>
          <p id="P2">Current address: Penn State University, University Park, PA.</p>
        </fn>
        <corresp id="CR1"><bold>Address correspondence and reprint requests:</bold> David W. Pascual, Professor of Immunology, Department of Infectious Diseases &amp; Immunology, University of Florida, 1945 S.W. 16<sup>th</sup> Ave., Gainesville, FL 32608. <email>pascuald@ufl.edu</email></corresp>
        <fn fn-type="COI-statement" id="FN3">
          <p id="P45">Disclosures</p>
          <p id="P46">The authors have no financial conflicts of interest.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>20</day>
        <month>3</month>
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>5</month>
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>15</day>
        <month>5</month>
        <year>2024</year>
      </pub-date>
      <volume>210</volume>
      <issue>10</issue>
      <fpage>1576</fpage>
      <lpage>1588</lpage>
      <abstract id="ABS1">
        <p id="P3">The <italic toggle="yes">Brucella abortus</italic> double-mutant (znBAZ) was assessed for its protective efficacy following vaccination with a single, nasal dose. Superior protection was achieved in znBAZ-vaccinated mice against pulmonary, wild-type <italic toggle="yes">B. abortus</italic> 2308 challenge when compared to conventional livestock <italic toggle="yes">Brucella abortus</italic> vaccines, the smooth S19 and rough RB51 strains. Nasal znBAZ vaccination reduced splenic and lung colonization by wild-type brucellae by more than 3&#x2013;4 logs. In contrast, S19 reduced lung colonization by only 32-fold, and RB51 failed to reduce colonization. One profound attribute of znBAZ vaccination was the &gt;three-fold increase in pulmonary CD8<sup>+</sup> T cells when compared to other vaccinated groups. S19 vaccination increased only CD4<sup>+</sup> T cells. All vaccines induced IFN-&#x3B3; and TNF-&#x3B1; production by CD4<sup>+</sup> T cells, but only znBAZ vaccination enhanced the recruitment of polyfunctional CD8<sup>+</sup> T cells, by &gt;100-fold. IL-17 by both CD4<sup>+</sup> and CD8<sup>+</sup> T cells was also induced subsequent znBAZ vaccination. These results demonstrate that, in addition to achieving protective immunity by CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells, specifically, resident memory T cells, also confer protection against brucellosis. The protection obtained by znBAZ vaccination was attributed to IFN-&#x3B3;-producing CD8<sup>+</sup> T cells, since depletion of CD8<sup>+</sup> T cells throughout vaccination and challenge phases, abrogated protection. The stimulation of only CD4<sup>+</sup> T cells by RB51- and S19-vaccinated mice proved insufficient in protecting against pulmonary <italic toggle="yes">B. abortus</italic> 2308 challenge. Thus, nasal znBAZ vaccination offers an alternative means to elicit protection against brucellosis.</p>
      </abstract>
      <kwd-group>
        <kwd>
          <italic toggle="yes">Brucella</italic>
        </kwd>
        <kwd>vaccines</kwd>
        <kwd>nasal immunization</kwd>
        <kwd>T cells</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>
</pmc-articleset>